{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:43:14Z","timestamp":1793317394646,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Medical Innovation Center of Kidney Disease","award":["CXZX202202"],"award-info":[{"award-number":["CXZX202202"]}]},{"name":"the Key Research and Development Program of Jiangsu Province","award":["BE2022825"],"award-info":[{"award-number":["BE2022825"]}]},{"name":"the Medical Research Project of Jiangsu Commission of Health","award":["K2023003"],"award-info":[{"award-number":["K2023003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03108-4","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T12:01:17Z","timestamp":1738670477000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["RGD-HSA-TAC nanoparticles targeted delivery of tacrolimus and attenuation of podocyte injury in diabetic kidney disease"],"prefix":"10.1186","volume":"23","author":[{"given":"Zhaochen","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zige","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinger","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaojie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weisong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"issue":"6","key":"3108_CR1","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00125-018-4557-7","volume":"61","author":"RCW Ma","year":"2018","unstructured":"Ma RCW. Epidemiology of diabetes and diabetic complications in China. Diabetologia. 2018;61(6):1249\u201360.","journal-title":"Diabetologia"},{"issue":"2","key":"3108_CR2","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1172\/JCI119163","volume":"99","author":"ME Pagtalunan","year":"1997","unstructured":"Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest. 1997;99(2):342\u20138.","journal-title":"J Clin Invest"},{"issue":"3","key":"3108_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41584-020-0374-8","volume":"16","author":"JCA Broen","year":"2020","unstructured":"Broen JCA, van Laar JM. Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology. Nat Rev Rheumatol. 2020;16(3):167\u201378.","journal-title":"Nat Rev Rheumatol"},{"key":"3108_CR4","doi-asserted-by":"publisher","first-page":"8832114","DOI":"10.1155\/2021\/8832114","volume":"2021","author":"R Ma","year":"2021","unstructured":"Ma R, Wang Y, Xu Y, Wang R, Wang X, Yu N, et al. Tacrolimus protects podocytes from apoptosis via downregulation of TRPC6 in diabetic nephropathy. J Diabetes Res. 2021;2021:8832114.","journal-title":"J Diabetes Res"},{"issue":"10","key":"3108_CR5","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.tips.2021.07.001","volume":"42","author":"YS Zhu","year":"2021","unstructured":"Zhu YS, Tang K, Lv J. Peptide\u2013drug conjugate-based novel molecular drug delivery system in cancer. Trends Pharmacol Sci. 2021;42(10):857\u201369.","journal-title":"Trends Pharmacol Sci"},{"key":"3108_CR6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1146\/annurev.cellbio.12.1.697","volume":"12","author":"E Ruoslahti","year":"1996","unstructured":"Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol. 1996;12:697\u2013715.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"18","key":"3108_CR7","doi-asserted-by":"publisher","first-page":"18008","DOI":"10.1021\/acsnano.3c04423","volume":"17","author":"Y Xie","year":"2023","unstructured":"Xie Y, Sun Y, Liu Y, Zhao J, Liu Q, Xu J, et al. Targeted delivery of RGD-CD146+CD271+ human umbilical cord mesenchymal stem cell-derived exosomes promotes blood-spinal cord barrier repair after spinal cord injury. ACS Nano. 2023;17(18):18008\u201324.","journal-title":"ACS Nano"},{"issue":"42","key":"3108_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409081","volume":"11","author":"M Ma","year":"2024","unstructured":"Ma M, Li X, Jing M, Zhang P, Zhang M, Wang L, et al. Enhanced tumor-targeted delivery of arginine-rich peptides via a positive feedback loop orchestrated by piezo1\/integrin beta1 signaling axis. Adv Sci. 2024;11(42): e2409081.","journal-title":"Adv Sci"},{"issue":"3","key":"3108_CR9","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1148\/radiol.2016150813","volume":"281","author":"X Jin","year":"2016","unstructured":"Jin X, Liang N, Wang M, Meng Y, Jia B, Shi X, et al. Integrin imaging with 99mTc-3PRGD2 SPECT\/CT shows high specificity in the diagnosis of lymph node metastasis from non-small cell lung cancer. Radiology. 2016;281(3):958\u201366.","journal-title":"Radiology"},{"key":"3108_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.msec.2017.08.004","volume":"81","author":"RR Kudarha","year":"2017","unstructured":"Kudarha RR, Sawant KK. Albumin based versatile multifunctional nanocarriers for cancer therapy: fabrication, surface modification, multimodal therapeutics and imaging approaches. Mater Sci Eng C Mater Biol Appl. 2017;81:607\u201326.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"2","key":"3108_CR11","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1021\/acsnano.1c08536","volume":"16","author":"G Yang","year":"2022","unstructured":"Yang G, Wang D, Phua SZF, Bindra AK, Qian C, Zhang R, et al. Albumin-based therapeutics capable of glutathione consumption and hydrogen peroxide generation for synergetic chemodynamic and chemotherapy of cancer. ACS Nano. 2022;16(2):2319\u201329.","journal-title":"ACS Nano"},{"key":"3108_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cis.2017.06.012","volume":"246","author":"B Bhushan","year":"2017","unstructured":"Bhushan B, Khanadeev V, Khlebtsov B, Khlebtsov N, Gopinath P. Impact of albumin based approaches in nanomedicine: imaging, targeting and drug delivery. Adv Colloid Interface Sci. 2017;246:13\u201339.","journal-title":"Adv Colloid Interface Sci"},{"key":"3108_CR13","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.jconrel.2022.11.017","volume":"352","author":"S Liu","year":"2022","unstructured":"Liu S, Lv K, Wang Y, Lou P, Zhou P, Wang C, et al. Improving the circulation time and renal therapeutic potency of extracellular vesicles using an endogenous ligand binding strategy. J Control Release. 2022;352:1009\u201323.","journal-title":"J Control Release"},{"issue":"7","key":"3108_CR14","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2023.06.006","volume":"56","author":"B Voisin","year":"2023","unstructured":"Voisin B, Nadella V, Doebel T, Goel S, Sakamoto K, Ayush O, et al. Macrophage-mediated extracellular matrix remodeling controls host Staphylococcus aureus susceptibility in the skin. Immunity. 2023;56(7):1561\u201377.e9.","journal-title":"Immunity"},{"key":"3108_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pupt.2016.01.001","volume":"36","author":"J Seo","year":"2016","unstructured":"Seo J, Lee C, Hwang HS, Kim B, le Thao Q, Lee ES, et al. Therapeutic advantage of inhaled tacrolimus-bound albumin nanoparticles in a bleomycin-induced pulmonary fibrosis mouse model. Pulm Pharmacol Ther. 2016;36:53\u201361.","journal-title":"Pulm Pharmacol Ther"},{"issue":"6","key":"3108_CR16","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1166\/jbn.2019.2777","volume":"15","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Pan J, Li H, Yu D, Wu T, Wang L, et al. Albumin based nanomedicine for enhancing tacrolimus safety and lymphatic targeting efficiency. J Biomed Nanotechnol. 2019;15(6):1313\u201324.","journal-title":"J Biomed Nanotechnol"},{"key":"3108_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2024.102385","volume":"57","author":"S Gao","year":"2024","unstructured":"Gao S, Li Y, Zhu T, Guo Z, Hu Y, Wang Y, et al. rs-TAC PDC, a peptide drug-conjugate, for targeted delivery of tacrolimus and sericin alleviates podocyte injury in diabetic nephropathy. Nano Today. 2024;57: 102385.","journal-title":"Nano Today"},{"issue":"10","key":"3108_CR18","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.3390\/pharmaceutics13101576","volume":"13","author":"M Bodnar-Broniarczyk","year":"2021","unstructured":"Bodnar-Broniarczyk M, Durlik M, Baczkowska T, Czerwinska K, Marszalek R, Pawinski T. Kidney and liver tissue tacrolimus concentrations in adult transplant recipients\u2014the influence of the whole blood and tissue concentrations on efficiency of treatment during immunosuppressive therapy. Pharmaceutics. 2021;13(10):1576.","journal-title":"Pharmaceutics"},{"issue":"3","key":"3108_CR19","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41565-021-00858-8","volume":"16","author":"JJ Rennick","year":"2021","unstructured":"Rennick JJ, Johnston APR, Parton RG. Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics. Nat Nanotechnol. 2021;16(3):266\u201376.","journal-title":"Nat Nanotechnol"},{"issue":"3","key":"3108_CR20","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20192373","volume":"218","author":"S Hu","year":"2021","unstructured":"Hu S, Han R, Chen L, Qin W, Xu X, Shi J, et al. Upregulated LRRC55 promotes BK channel activation and aggravates cell injury in podocytes. J Exp Med. 2021;218(3): e20192373.","journal-title":"J Exp Med"},{"key":"3108_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2020.118298","volume":"235","author":"M Amoorahim","year":"2020","unstructured":"Amoorahim M, Ashrafi-Kooshk MR, Esmaeili S, Shahlaei M, Moradi S, Khodarahmi R. Physiological changes in the albumin-bound non-esterified free fatty acids critically influence heme\/bilirubin binding properties of the protein: a comparative, in vitro, spectroscopic study using the endogenous biomolecules. Spectrochim Acta A Mol Biomol Spectrosc. 2020;235: 118298.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"2","key":"3108_CR22","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1021\/acsabm.2c00946","volume":"6","author":"D Singh","year":"2023","unstructured":"Singh D, Qasam I, Paudwal G, Kotwal P, Behera C, Kumar A, et al. Redox-responsive hyaluronic acid-tacrolimus conjugate: synthesis, characterization, and in vitro immunosuppressive activity. ACS Appl Bio Mater. 2023;6(2):733\u201344.","journal-title":"ACS Appl Bio Mater"},{"issue":"4","key":"3108_CR23","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.kint.2023.06.021","volume":"104","author":"N Lloberas","year":"2023","unstructured":"Lloberas N, Grinyo JM, Colom H, Vidal-Alabro A, Fontova P, Rigo-Bonnin R, et al. A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian prediction. Kidney Int. 2023;104(4):840\u201350.","journal-title":"Kidney Int"},{"issue":"7","key":"3108_CR24","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.3390\/ijms25073969","volume":"25","author":"A Mazzieri","year":"2024","unstructured":"Mazzieri A, Porcellati F, Timio F, Reboldi G. Molecular targets of novel therapeutics for diabetic kidney disease: a new era of nephroprotection. Int J Mol Sci. 2024;25(7):3969.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3108_CR25","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.dsx.2018.11.054","volume":"13","author":"V Rao","year":"2019","unstructured":"Rao V, Rao LBV, Tan SH, Candasamy M, Bhattamisra SK. Diabetic nephropathy: an update on pathogenesis and drug development. Diabetes Metab Syndr. 2019;13(1):754\u201362.","journal-title":"Diabetes Metab Syndr"},{"issue":"10","key":"3108_CR26","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.drudis.2015.06.003","volume":"20","author":"MA Lal","year":"2015","unstructured":"Lal MA, Young KW, Andag U. Targeting the podocyte to treat glomerular kidney disease. Drug Discov Today. 2015;20(10):1228\u201334.","journal-title":"Drug Discov Today"},{"key":"3108_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jconrel.2021.04.016","volume":"334","author":"Y Huang","year":"2021","unstructured":"Huang Y, Wang J, Jiang K, Chung EJ. Improving kidney targeting: the influence of nanoparticle physicochemical properties on kidney interactions. J Control Release. 2021;334:127\u201337.","journal-title":"J Control Release"},{"issue":"6","key":"3108_CR28","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41581-024-00819-z","volume":"20","author":"Y Huang","year":"2024","unstructured":"Huang Y, Ning X, Ahrari S, Cai Q, Rajora N, Saxena R, et al. Physiological principles underlying the kidney targeting of renal nanomedicines. Nat Rev Nephrol. 2024;20(6):354\u201370.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"3108_CR29","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/nep.12991","volume":"22","author":"D Xu","year":"2017","unstructured":"Xu D, Gao X, Bian R, Mei C, Xu C. Tacrolimus improves proteinuria remission in adults with cyclosporine A-resistant or -dependent minimal change disease. Nephrology. 2017;22(3):251\u20136.","journal-title":"Nephrology"},{"issue":"3","key":"3108_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/ndt\/gfu306","volume":"30","author":"J Caro","year":"2015","unstructured":"Caro J, Gutierrez-Solis E, Rojas-Rivera J, Agraz I, Ramos N, Rabasco C, et al. Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus. Nephrol Dial Transplant. 2015;30(3):467\u201374.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"3108_CR31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000346256","volume":"37","author":"H Ren","year":"2013","unstructured":"Ren H, Shen P, Li X, Pan X, Zhang W, Chen N. Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial. Am J Nephrol. 2013;37(1):84\u201390.","journal-title":"Am J Nephrol"},{"issue":"9","key":"3108_CR32","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nm.1857","volume":"14","author":"C Faul","year":"2008","unstructured":"Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med. 2008;14(9):931\u20138.","journal-title":"Nat Med"},{"issue":"5","key":"3108_CR33","doi-asserted-by":"publisher","first-page":"F798","DOI":"10.1152\/ajprenal.00055.2017","volume":"314","author":"Y Yuan","year":"2018","unstructured":"Yuan Y, Zhang A, Qi J, Wang H, Liu X, Zhao M, et al. p53\/Drp1-dependent mitochondrial fission mediates aldosterone-induced podocyte injury and mitochondrial dysfunction. Am J Physiol Renal Physiol. 2018;314(5):F798\u2013808.","journal-title":"Am J Physiol Renal Physiol"},{"key":"3108_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.126067","volume":"250","author":"M Saad","year":"2023","unstructured":"Saad M, El-Samad LM, Gomaa RA, Augustyniak M, Hassan MA. A comprehensive review of recent advances in silk sericin: extraction approaches, structure, biochemical characterization, and biomedical applications. Int J Biol Macromol. 2023;250: 126067.","journal-title":"Int J Biol Macromol"},{"issue":"22","key":"3108_CR35","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.3390\/polym14224931","volume":"14","author":"AS Silva","year":"2022","unstructured":"Silva AS, Costa EC, Reis S, Spencer C, Calhelha RC, Miguel SP, et al. Silk sericin: a promising sustainable biomaterial for biomedical and pharmaceutical applications. Polymers. 2022;14(22):4931.","journal-title":"Polymers"},{"issue":"1","key":"3108_CR36","doi-asserted-by":"publisher","first-page":"7064","DOI":"10.1038\/srep07064","volume":"4","author":"Z Wang","year":"2014","unstructured":"Wang Z, Zhang Y, Zhang J, Huang L, Liu J, Li Y, et al. Exploring natural silk protein sericin for regenerative medicine: an injectable, photoluminescent, cell-adhesive 3D hydrogel. Sci Rep. 2014;4(1):7064.","journal-title":"Sci Rep"},{"key":"3108_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121638","volume":"287","author":"J Liu","year":"2022","unstructured":"Liu J, Shi L, Deng Y, Zou M, Cai B, Song Y, et al. Silk sericin-based materials for biomedical applications. Biomaterials. 2022;287: 121638.","journal-title":"Biomaterials"},{"key":"3108_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jconrel.2022.11.019","volume":"353","author":"D Hu","year":"2023","unstructured":"Hu D, Li T, Liang W, Wang Y, Feng M, Sun J. Silk sericin as building blocks of bioactive materials for advanced therapeutics. J Control Release. 2023;353:303\u201316.","journal-title":"J Control Release"},{"key":"3108_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119289","volume":"581","author":"AL Martinez-Lopez","year":"2020","unstructured":"Martinez-Lopez AL, Pangua C, Reboredo C, Campion R, Morales-Gracia J, Irache JM. Protein-based nanoparticles for drug delivery purposes. Int J Pharm. 2020;581: 119289.","journal-title":"Int J Pharm"},{"issue":"8","key":"3108_CR40","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.annonc.2021.05.801","volume":"32","author":"D Miles","year":"2021","unstructured":"Miles D, Gligorov J, Andre F, Cameron D, Schneeweiss A, Barrios C, et al. Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced\/metastatic triple-negative breast cancer. Ann Oncol. 2021;32(8):994\u20131004.","journal-title":"Ann Oncol"},{"issue":"15","key":"3108_CR41","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.7150\/thno.19365","volume":"7","author":"FF An","year":"2017","unstructured":"An FF, Zhang XH. Strategies for preparing albumin-based nanoparticles for multifunctional bioimaging and drug delivery. Theranostics. 2017;7(15):3667\u201389.","journal-title":"Theranostics"},{"issue":"3","key":"3108_CR42","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1039\/D0CS00556H","volume":"50","author":"BM Cooper","year":"2021","unstructured":"Cooper BM, Iegre J, O\u2019Donovan DH, Halvarsson MO, Spring DR. Peptides as a platform for targeted therapeutics for cancer: peptide\u2013drug conjugates (PDCs). Chem Soc Rev. 2021;50(3):1480\u201394.","journal-title":"Chem Soc Rev"},{"issue":"8","key":"3108_CR43","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/nbt.3298","volume":"33","author":"A Wittrup","year":"2015","unstructured":"Wittrup A, Ai A, Liu X, Hamar P, Trifonova R, Charisse K, et al. Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown. Nat Biotechnol. 2015;33(8):870\u20136.","journal-title":"Nat Biotechnol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03108-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03108-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03108-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T23:28:35Z","timestamp":1738711715000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03108-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3108"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03108-4","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Ethics Committee of the Affiliated Jinling Hospital, Medical School of Nanjing University (Document number 2022DZSJJDWLS-0019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors agree for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}